(020) 7242 5778

Wildy’s Book News

Book News cover photo

Vol 24 No 7 July/August 2019

Book of the Month

Cover of The Law and Practice of International Finance: Set of 9 Volumes

The Law and Practice of International Finance: Set of 9 Volumes

Price: £2235.00

Offers for Newly Called Barristers & Students

Special Discounts for Newly Called & Students

Read More ...

Secondhand & Out of Print

Browse Secondhand Online


Competition Policy in Healthcare: A Comparative Study of England and the Netherlands

ISBN13: 9781780686493
Published: January 2019
Publisher: Intersentia Publishers
Country of Publication: UK
Format: Hardback
Price: £75.00

Usually despatched in 1 to 3 weeks.

This book examines competition policy (competition law, merger control and sectoral regulation) in English and Dutch healthcare. In contrast to the United States, competition in English and Dutch healthcare develops from the principle of universal access to healthcare, which appears antithetical to competition. Unsurprisingly, competition reforms in both a health insurance system (the Netherlands) and a taxation-funded National Health Service (NHS) (England) have proved controversial. Such reforms are also proving difficult to implement, with both countries developing “healthcare-specific” modifications of general competition rules and differing relationships between the competition authorities and healthcare regulators in applying these.

This book challenges both existing literature and the policy underpinning the reforms by adopting the position that healthcare is fundamentally different to other liberalized sectors and thus requires special treatment. Furthermore, it argues that different approaches are needed to accommodate the specific characteristics of national healthcare systems (such as the tension between the NHS and private healthcare in the UK) within the wider typology of insurance-based and taxation-funded systems across Europe. It also provides a first context-based comparative law study in this area.

This analysis is timely in light of ongoing criticism of the reforms and current refocusing of competition within healthcare in both countries.